Steal This Idea: Why Judaism Says No to Microlooting
Neuralink's Blindsight brain implant is gearing up for its first human trials in 2026—pending final regulatory approvals.
This device stimulates the visual cortex directly, bypassing damaged eyes or optic nerves entirely, to restore vision even in cases of total blindness (including from birth). It starts with low-resolution perception (think early video game graphics) but is designed to improve significantly over time, potentially offering enhanced capabilities down the line.
With 21+ participants already thriving on Neuralink's Telepathy implants for thought-controlled devices, the team is scaling up production and automation—bringing us closer to life-changing autonomy for the blind.
